Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vertex Pharmaceuticals Inc (VRTX)  
$443.05 1.92 (0.44%) as of 4:30 Thu 5/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 260,040,000
Market Cap: 115.21(B)
Last Volume: 975,365 Avg Vol: 1,608,800
52 Week Range: $323.62 - $456.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 400 MIDCAP     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  543
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vertex Pharmaceuticals is a biotechnology company. Co. has clinical and research programs to develop treatment of cystic fibrosis. In addition, Co. has a pipeline of investigational therapies in other diseases where it is utilizing insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. Co.'s marketed CF medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 23,137 144,475 259,873 619,971
Total Sell Value $10,319,530 $60,539,246 $102,205,755 $209,876,745
Total People Sold 7 12 14 18
Total Sell Transactions 7 40 65 130
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 3277
  Page 23 of 132  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Parini Michael EVP, Chief Adm, Leg & BD Off   •       –      –    2020-05-11 4 AS $286.00 $372,944 D/D (1,304) 26,838 -7%     
   Parini Michael EVP, Chief Adm, Leg & BD Off   •       –      –    2020-05-11 4 OE $187.53 $244,539 D/D 1,304 28,142     -
   Leiden Jeffrey M Executive Chairman   •       •      –    2020-05-07 4 AS $267.52 $25,459,013 D/D (94,369) 40,821 3%     
   Leiden Jeffrey M Executive Chairman   •       •      –    2020-05-07 4 OE $91.05 $12,174,982 D/D 88,534 135,190     -
   Sachs Bruce I Director   –       •      –    2020-05-07 4 AS $267.50 $12,140,806 D/D (45,000) 11,210 3%     
   Sachs Bruce I Director   –       •      –    2020-05-07 4 OE $59.55 $3,174,525 D/D 45,000 56,210     -
   Parini Michael EVP, Chief Adm, Leg & BD Off   •       –      –    2020-05-06 4 AS $270.16 $333,165 D/D (1,222) 26,838 1%     
   Parini Michael EVP, Chief Adm, Leg & BD Off   •       –      –    2020-05-06 4 OE $155.57 $190,107 D/D 1,222 28,060     -
   Silva Paul M SVP & Controller   •       –      –    2020-05-06 4 AS $269.41 $293,472 D/D (1,076) 14,932 1%     
   Silva Paul M SVP & Controller   •       –      –    2020-05-06 4 OE $155.57 $182,255 D/D 1,076 16,008     -
   Kewalramani Reshma CEO & President   •       •      –    2020-05-06 4 AS $270.35 $565,882 D/D (2,074) 26,626 1%     
   Kewalramani Reshma CEO & President   •       •      –    2020-05-06 4 OE $155.57 $372,638 D/D 2,074 28,700     -
   Altshuler David EVP, Global Research and CSO   •       –      –    2020-05-06 4 AS $270.20 $333,195 D/D (1,222) 28,902 1%     
   Altshuler David EVP, Global Research and CSO   •       –      –    2020-05-06 4 OE $155.57 $190,107 D/D 1,222 30,124     -
   Sachdev Amit EVP, Chief Patient Officer   •       –      –    2020-05-06 4 AS $275.28 $184,162 D/D (669) 35,103 1%     
   Sachdev Amit EVP, Chief Patient Officer   •       –      –    2020-05-06 4 OE $131.89 $88,234 D/D 669 35,772     -
   Tatsis Ourania EVP, Chief Regulatory Officer   •       –      –    2020-05-06 4 AS $268.80 $263,431 D/D (966) 12,738 1%     
   Tatsis Ourania EVP, Chief Regulatory Officer   •       –      –    2020-05-06 4 OE $155.57 $168,146 D/D 966 13,704     -
   Leiden Jeffrey M Executive Chairman   •       •      –    2020-05-05 4 AS $265.57 $25,475,037 D/D (94,372) 46,656 1%     
   Leiden Jeffrey M Executive Chairman   •       •      –    2020-05-05 4 OE $91.05 $12,175,273 D/D 88,537 141,028     -
   Sachdev Amit EVP, Chief Patient Officer   •       –      –    2020-05-05 4 AS $265.72 $3,606,232 D/D (13,356) 35,103 1%     
   Sachdev Amit EVP, Chief Patient Officer   •       –      –    2020-05-05 4 OE $131.89 $1,761,523 D/D 13,356 48,459     -
   Altshuler David EVP, Global Research and CSO   •       –      –    2020-05-04 4 AS $259.18 $607,803 D/D (2,330) 28,902 0%     
   Altshuler David EVP, Global Research and CSO   •       –      –    2020-05-04 4 OE $86.52 $201,592 D/D 2,330 31,232     -
   Sachdev Amit EVP, Chief Patient Officer   •       –      –    2020-05-04 4 AS $258.59 $11,475,179 D/D (43,752) 35,103 0%     
  3277 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 23 of 132
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us